Advisory Alpha LLC Takes $66,000 Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Advisory Alpha LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,625 shares of the company’s stock, valued at approximately $66,000.

A number of other hedge funds have also added to or reduced their stakes in XPH. JPMorgan Chase & Co. lifted its position in SPDR S&P Pharmaceuticals ETF by 2,405.4% during the third quarter. JPMorgan Chase & Co. now owns 119,083 shares of the company’s stock valued at $5,782,000 after purchasing an additional 114,330 shares during the last quarter. Bank of Montreal Can lifted its position in SPDR S&P Pharmaceuticals ETF by 15.4% during the fourth quarter. Bank of Montreal Can now owns 4,580 shares of the company’s stock valued at $168,000 after purchasing an additional 610 shares during the last quarter. Corient Capital Partners LLC bought a new position in SPDR S&P Pharmaceuticals ETF during the fourth quarter valued at $959,000. LPL Financial LLC lifted its position in SPDR S&P Pharmaceuticals ETF by 184.7% during the fourth quarter. LPL Financial LLC now owns 53,532 shares of the company’s stock valued at $1,960,000 after purchasing an additional 34,732 shares during the last quarter. Finally, PNC Financial Services Group Inc. lifted its position in SPDR S&P Pharmaceuticals ETF by 30.9% during the fourth quarter. PNC Financial Services Group Inc. now owns 34,849 shares of the company’s stock valued at $1,276,000 after purchasing an additional 8,222 shares during the last quarter.

XPH stock opened at $37.70 on Thursday. SPDR S&P Pharmaceuticals ETF has a 52 week low of $34.51 and a 52 week high of $49.97.

ILLEGAL ACTIVITY NOTICE: “Advisory Alpha LLC Takes $66,000 Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)” was first published by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://transcriptdaily.com/2019/06/13/advisory-alpha-llc-takes-66000-position-in-spdr-sp-pharmaceuticals-etf-nysearcaxph.html.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Recommended Story: Understanding debt-to-equity ratio in fundamental analysis

Want to see what other hedge funds are holding XPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH).

Institutional Ownership by Quarter for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.